XETRA - Delayed Quote EUR
Johnson & Johnson (JNJ.DE)
138.20
-0.40
(-0.29%)
As of 12:48:47 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 20 | 21 |
| Avg. Estimate | 22.85B | 23.1B | 91.35B | 94.98B |
| Low Estimate | 22.51B | 22.91B | 90.82B | 93.09B |
| High Estimate | 23.09B | 23.24B | 91.87B | 96.65B |
| Year Ago Sales | 22.45B | 22.47B | 88.82B | 91.35B |
| Sales Growth (year/est) | 1.78% | 2.80% | 2.85% | 3.98% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| JNJ.DE | -- | -- | -- | -- |
| S&P 500 | 12.50% | 3.24% | 7.95% | 13.84% |
Upgrades & Downgrades
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/17/2025 |
| Maintains | Raymond James: Outperform to Outperform | 4/16/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/16/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 4/16/2025 |
| Maintains | Raymond James: Outperform to Outperform | 4/14/2025 |
| Maintains | B of A Securities: Neutral to Neutral | 4/10/2025 |
Related Tickers
4AB.DE AbbVie Inc.
163.20
-2.04%
C43.DE Cosmo Pharmaceuticals N.V.
50.00
+2.46%
GIS.DE Gilead Sciences, Inc.
86.40
-0.94%
IDP.DE Biogen Inc.
103.85
+0.34%
BRM.DE Bristol-Myers Squibb Company
41.71
-0.94%
SNW.DE Sanofi
92.18
+0.94%
1SAN.MI Sanofi
93.27
+1.44%
GS71.DE GSK plc
16.31
0.00%
6MK.DE Merck & Co., Inc.
69.70
-0.85%
ZEG.DE AstraZeneca PLC
121.00
-2.02%